Ruthsarian
Home
Sitemap
Q & A
Notice Board
PhEpi & PhV activities
Research Funding
Conferences & meetings
Recruitment
Links
Contact Us
Links to Data sources
Sr. No
Display Name
Type
Country
Last Updated
1
OPED
Data Source
Denmark
27/07/2023
Links to Studies
Status
Official Title
Lead Investigator
Last Updated
Finalised
Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus, Pimecrolimus, and Corticosteroids
Dr Jordi Castellsague
24/03/2022
Finalised
Dynamics of prescription drug use, diagnoses and health care utilization after community managed SARS-CoV-2 infection
Professor Anton Pottegård
25/05/2021
Finalised
Impact of use of proton pump inhibitors on susceptibility to infection and risk of hospitalisation in patients with COVID-19
Dr Simone Bastrup Israelsen
17/05/2021
Finalised
Impact of use of newer glucose lowering drugs on outcomes in patients with COVID-19
Dr Simone Bastrup Israelsen
21/03/2021
Finalised
Risk and course of COVID-19 infection in patients with hypo- or hyperthyroidism. A Danish population-based cohort study
Professor Jesper Hallas
11/03/2021
Finalised
Inhaled corticosteroids and COVID-19 morbidity: Nationwide cohort study
Mr Anders Husby
11/03/2021
Finalised
Renin-angiotensin-aldosterone system inhibitors and adverse outcomes of COVID-19: a Danish nationwide cohort study
Professor Henrik Toft Sørensen
10/12/2020
Finalised
Post-Authorization Safety Program—Validation of the Danish Data Resources for the Study of Cardiovascular and Neoplasm Events in Users of Treatments for Overactive Bladder
Dr Alejandro Arana
10/04/2019
Finalised
Evaluation of potential off-label use of dabigatran etexilate in Europe
Dr Manel Pladevall-Vila
20/09/2018
Finalised
Evaluation of the Use of Nepafenac in Selected European Populations
Dr Alejandro Arana Navarro
25/07/2017
Ongoing
NN9535-4447 Epidemiological assessment of the risk for pancreatic cancer associated with the use of semaglutide in patients with type 2 diabetes- A cohort study based on Nordic registry data
Professor Anton Pottegård
10/10/2022
Ongoing
The prognosis of coronavirus disease (COVID-19) in patients recently treated with immunosuppressant medications.
Professor Jesper Hallas
15/06/2021
Ongoing
The effect of mental disorders and treatment with psychotropic agents on the course of COVID-19
Dr Christiane Gasse
11/03/2021
Ongoing
Use of non-steroidal anti-inflammatory drugs and clinical outcome of COVID-19: a Danish nationwide cohort study
Professor Anton Pottegård
21/04/2020
Planned
Use of Low-dose Quetiapine and the Risk of Major Adverse Cardiovascular Events
Mr Mikkel Højlund
22/11/2021
Planned
The BRodalumab Assessment of Hazards: A Multinational Safety (BRAHMS) study in electronic healthcare databases
Professor Jesper Hallas
05/10/2021
Planned
Drug-drug interactions between dicloxacillin/flucloxacillin and DOACs
Professor Anton Pottegård
16/11/2020
News
About Us
ENCePP Documents
Training in PhEpi and PV
Code of Conduct
Standards & Guidances
ENCePP Study Seal
Public Consultation
Glossary of terms
Resources Database
Partners forum
EU PAS Register
About EU PAS Register